How Roswell Park Is Rethinking Molecular Testing for Blood Cancers with Sean Glenn

A fully automated, combined DNA/RNA NGS panel can deliver guideline-compliant blood cancer results in 2.5 days, replacing fragmented single-gene testing.

• PanHeme assay design: Roswell Park's comprehensive panel targets ~400 DNA genes and ~125 RNA genes to cover both myeloid and lymphoid blood cancers in one test.
• Speed via automation: Robotic library prep (overnight vs. 2.5 days by hand) and fully automated informatics/EHR pipeline cut turnaround to an average of 2.5 days for 50-60 weekly tests.

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.